The study was published in The Journal of Bone and Joint Surgery and conducted on more than 7,000 patients undergoing the procedures at New England Baptist Hospital in Boston.
The prescreening program employed a”rapid polymerase chain reaction analysis of nasal swabs followed by an eradication protocol of intranasal mupirocin and chlorhexidine showers for identified carriers,” according to the study’s abstract.
Read the abstract of the study on prescreening staph.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
